Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7818 | 1246 | 41.8 | 85% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ONO 1301 | Author keyword | 26 | 100% | 1% | 11 |
2 | IP RECEPTOR | Author keyword | 16 | 56% | 2% | 20 |
3 | EP4 RECEPTOR | Author keyword | 15 | 39% | 2% | 31 |
4 | PROSTACYCLIN RECEPTOR | Author keyword | 15 | 51% | 2% | 21 |
5 | PROSTANOID RECEPTORS | Author keyword | 13 | 37% | 2% | 29 |
6 | EP3 RECEPTOR | Author keyword | 11 | 42% | 2% | 20 |
7 | PROSTANOID RECEPTOR | Author keyword | 11 | 39% | 2% | 22 |
8 | EP RECEPTORS | Author keyword | 9 | 29% | 2% | 26 |
9 | EP4 | Author keyword | 8 | 31% | 2% | 22 |
10 | EP3 RECEPTOR ANTAGONISTS | Author keyword | 8 | 100% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ONO 1301 | 26 | 100% | 1% | 11 | Search ONO+1301 | Search ONO+1301 |
2 | IP RECEPTOR | 16 | 56% | 2% | 20 | Search IP+RECEPTOR | Search IP+RECEPTOR |
3 | EP4 RECEPTOR | 15 | 39% | 2% | 31 | Search EP4+RECEPTOR | Search EP4+RECEPTOR |
4 | PROSTACYCLIN RECEPTOR | 15 | 51% | 2% | 21 | Search PROSTACYCLIN+RECEPTOR | Search PROSTACYCLIN+RECEPTOR |
5 | PROSTANOID RECEPTORS | 13 | 37% | 2% | 29 | Search PROSTANOID+RECEPTORS | Search PROSTANOID+RECEPTORS |
6 | EP3 RECEPTOR | 11 | 42% | 2% | 20 | Search EP3+RECEPTOR | Search EP3+RECEPTOR |
7 | PROSTANOID RECEPTOR | 11 | 39% | 2% | 22 | Search PROSTANOID+RECEPTOR | Search PROSTANOID+RECEPTOR |
8 | EP RECEPTORS | 9 | 29% | 2% | 26 | Search EP+RECEPTORS | Search EP+RECEPTORS |
9 | EP4 | 8 | 31% | 2% | 22 | Search EP4 | Search EP4 |
10 | EP3 RECEPTOR ANTAGONISTS | 8 | 100% | 0% | 5 | Search EP3+RECEPTOR+ANTAGONISTS | Search EP3+RECEPTOR+ANTAGONISTS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROSTANOID RECEPTORS | 97 | 26% | 26% | 322 |
2 | EP3 SUBTYPE | 74 | 70% | 5% | 61 |
3 | EP2 SUBTYPE | 43 | 47% | 5% | 68 |
4 | PROSTAGLANDIN E RECEPTOR | 41 | 49% | 5% | 61 |
5 | PROSTACYCLIN RECEPTOR | 24 | 36% | 4% | 54 |
6 | ACYLSULFONAMIDE ANALOGS | 23 | 100% | 1% | 10 |
7 | OCTIMIBATE | 21 | 85% | 1% | 11 |
8 | INHALED PGE2 | 14 | 48% | 2% | 22 |
9 | PG SKELETON | 14 | 100% | 1% | 7 |
10 | THROMBOXANE A2 RECEPTOR | 13 | 26% | 3% | 42 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Prostaglandin E receptors | 2007 | 474 | 64 | 63% |
Prostaglandin E-2-induced inflammation: Relevance of prostaglandin E receptors | 2015 | 4 | 58 | 33% |
Prostanoid receptors: Structures, properties, and functions | 1999 | 1516 | 220 | 35% |
Regulation of Immune Responses by Prostaglandin E-2 | 2012 | 206 | 126 | 20% |
Prostanoid receptors: Subtypes and signaling | 2001 | 575 | 141 | 57% |
Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation | 2004 | 392 | 214 | 36% |
The PGE2-EP2-mast cell axis: An antiasthma mechanism | 2015 | 1 | 80 | 50% |
International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress | 2011 | 106 | 901 | 27% |
MOLECULAR MECHANISMS OF DIVERSE ACTIONS OF PROSTANOID RECEPTORS | 1995 | 303 | 72 | 60% |
Prostaglandins as modulators of immunity | 2002 | 627 | 65 | 22% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MINASE | 5 | 15% | 2.7% | 34 |
2 | P PHARMACOL PHARMACOL TOXICOL SECT | 3 | 50% | 0.3% | 4 |
3 | HEADQUARTERS | 2 | 11% | 1.5% | 19 |
4 | HERBERT | 2 | 67% | 0.2% | 2 |
5 | PHARMACEUT SCI PHYSIOL CHEM SAKYO KU | 2 | 67% | 0.2% | 2 |
6 | UMR S698 | 1 | 31% | 0.3% | 4 |
7 | INVITRO PHARMACOL | 1 | 100% | 0.2% | 2 |
8 | MED PHARMACOL SAKYO KU | 1 | 50% | 0.2% | 2 |
9 | FUKUI | 1 | 14% | 0.6% | 8 |
10 | PNEUMOL P ALLERGY | 1 | 18% | 0.5% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000195676 | MPGES 1//PROSTAGLANDIN E SYNTHASE//MPGES 2 |
2 | 0.0000187486 | GEORGE M OBRIEN KIDNEY UROL DIS//GEORGE OBRIEN KIDNEY UROL DIS//SERV 151 E |
3 | 0.0000166725 | CRTH2//MOL BEHAV BIOL//PROSTAGLANDIN D 2 |
4 | 0.0000142962 | NEUROINFLAMMAT S//MOL NEUROSCI UNIT//BUTAPROST |
5 | 0.0000132855 | EP1 ANTAGONIST//VISCERAL NOCICEPTOR//POLYMODAL RECEPTOR |
6 | 0.0000124276 | THROMBOXANE A2 RECEPTOR//THROMBOXANE RECEPTOR//THROMBOXANE A2 |
7 | 0.0000106138 | EXPT THER EUT PHARMACOINFORMAT//PROSTACYCLIN SYNTHASE GENE//PROSTACYCLIN SYNTHASE |
8 | 0.0000097647 | I EM NEURODEGENERAT BRAIN//BERAPROST SODIUM//NEONATE INFANT PATHOL |
9 | 0.0000093182 | CARBACYCLIN//CARBACYCLINS//SM 10906 |
10 | 0.0000078980 | POSITIVE BONE BALANCE//PROSTAGLANDIN ESTRADIOL PGE2//ENDOCRINOL METAB MC1850 |